Atrium Therapeutics Inc. (RNA)
NASDAQ: RNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
RNA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $135.65M
- EPS (TTM)
- -$5.42
- Dividend yield
- None
- 52-week range
- 7.63 – 16.77
- Day range
- 7.93 – 8.13
- Volume / Avg
- 91.81K / 255.56K
- Beta
- —
- Shares outstanding
- 17.11M
- Next earnings
- Nov 9, 2026
52-week range
RNA stock today
Atrium Therapeutics (RNA) closed at $7.93 on Oct 7, down 0.75% (-$0.06), versus the S&P 500's 0.22% decline. Trading was light, with 91.81K shares changing hands, about 36% of the average daily volume. Shares are 52.7% below their 52-week high of $16.77, set on Mar 5, 2026 and 3.9% above the 52-week low of $7.63, near the bottom of the past year's range.
Atrium Therapeutics has posted a net loss over the last twelve months (EPS of -$5.42), so its P/E ratio is not meaningful. Atrium Therapeutics's next earnings report is expected on Nov 9, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Atrium Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 9, 2026
Atrium Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CLLSCellectis S.A. ADR | 1.34 | -4.29% | $134.96M | vs RNA |
| OGIOrganigram Global Inc. | 0.96 | -1.04% | $138.39M | vs RNA |
| TLSATiziana Life Sciences Ltd. | 1.10 | -0.90% | $139.99M | vs RNA |
| TNXPTonix Pharmaceuticals Holding Corp. | 7.55 | -1.88% | $129.49M | vs RNA |
| SDEVStablecoin Development Corporation | 2.78 | -14.46% | $143.87M | vs RNA |
| SPRBSpruce Biosciences Inc. | 44.40 | +3.77% | $127.61M | vs RNA |
| HURATuHURA Biosciences Inc. | 1.98 | +1.54% | $126.18M | vs RNA |
| NRXPNRX Pharmaceuticals Inc. | 2.90 | -1.36% | $125.56M | vs RNA |
Indexes, lists and sector
Atrium Therapeutics stock FAQ
What is Atrium Therapeutics's stock price today?
RNA last traded at $7.93 as of Oct 7, 4:00 PM EDT, down 0.75% on the day. Prices are delayed at least 15 minutes.
When is Atrium Therapeutics's next earnings date?
Atrium Therapeutics is expected to report earnings on Monday, November 9, 2026.
What is the RNA 52-week high?
The 52-week high for RNA is $16.77 and the 52-week low is $7.63. The stock is currently 52.7% below its high.